Simplicity Solutions’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-4,256
Closed -$206K 1086
2023
Q3
$206K Sell
4,256
-5,370
-56% -$286K 0.01% 899
2023
Q2
$543K Buy
+9,626
New +$530K 0.01% 638
2022
Q2
Sell
-3,528
Closed -$215K 663
2022
Q1
$215K Sell
3,528
-3,528
-50% -$210K 0.03% 582
2021
Q4
$464K Buy
+7,056
New +$452K 0.05% 410
2021
Q1
Sell
-100,782
Closed -$5.5M 724
2020
Q4
$5.5M Buy
100,782
+43,080
+75% +$2.25M 0.08% 213
2020
Q3
$2.88M Sell
57,702
-85,644
-60% -$4.15M 0.05% 269
2020
Q2
$6.33M Buy
143,346
+108,102
+307% +$4.62M 0.13% 155
2020
Q1
$1.32M Sell
35,244
-20,154
-36% -$849K 0.04% 289
2019
Q4
$2.44M Buy
55,398
+47,208
+576% +$1.98M 0.07% 208
2019
Q3
$338K Buy
8,190
+906
+12% +$37.1K 0.01% 502
2019
Q2
$292K Sell
7,284
-1,014
-12% -$38.4K 0.01% 503
2019
Q1
$320K Buy
+8,298
New +$301K 0.02% 516
2018
Q4
Sell
-6,552
Closed -$248K 699
2018
Q3
$248K Buy
+6,552
New +$233K 0.01% 459

Other funds holding IHI

Simplicity Solutions's IHI Position: Q4 2023 in Review

Simplicity Solutions sold out of iShares US Medical Devices ETF (IHI) in Q4 2023, closing a stake of 4,256 shares — an estimated $206K sold.

Simplicity Solutions first reported a position in IHI in Q3 2018 and held it in 13 quarters. The position peaked at $6.33M in Q2 2020. 574 funds tracked by Wall St. Rank hold IHI as of Q4 2023.

  • Simplicity Solutions reported no remaining iShares US Medical Devices ETF position as of Q4 2023 after selling out during the quarter.
  • Simplicity Solutions sold 4,256 iShares US Medical Devices ETF shares in Q4 2023, an estimated $206K.
  • Simplicity Solutions first reported a position in iShares US Medical Devices ETF in Q3 2018 and held it in 13 quarters.
  • Simplicity Solutions's iShares US Medical Devices ETF position peaked at $6.33M in Q2 2020.
  • 574 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q4 2023.

Based on Simplicity Solutions's 13F filing for Q4 2023, filed 29 Jan 2024.